Nuclear Factor Kappa B

nuclear factor kappa light chain enhancer of activated B cells

Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model.

Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model.

The purpose of this study was to evaluate the effect of gliclazide on oxidative stress, inflammation, and bone loss in experimental periodontal disease model.Male albino Wistar rats were divided into no binder, binder, and a ligature with 1, 5, and 10 mg / kg of gliclazide group , Maxillary fixed and scanned using micro-computed tomography to measure linear and bone volume / tissue volume (BV / TV) and volumetric bone loss.

Histopathology, the analysis of immunohistochemistry and immunofluorescence performed to test the matrix metalloproteinase-2 (MMP-2), cyclooxygenase 2 (COX-2), cathepsin K, member activator receptor nuclear factor kappa-Β ligand (RANKL), an activator receptor nuclear factor kappa-Β (RANK), osteoprotegerin (OPG) pathway, the migration of macrophage inhibitory factor (MIF), superoxide dismutase-1 (SOD-1), glutathione peroxidase-1 (GPx-1), NFkB p 50 (cytoplasm), NLS NFkB p50 (signal nuclear localization), PI3 kinase and AKT staining. Myeloperoxidase activity, malondialdehyde and glutathione levels, while interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) levels were evaluated by ultraviolet-visible spectroscopy analysis.

A reverse transcription quantitative polymerase chain reaction was used to measure gene expression of nuclear factor kappa B subunit p50 (NF-kB p50), phosphoinositide 3-kinase (PI3K), protein kinase B (AKT) and F4 / 80.Micro tomography -computed showed that 1 mg / kg of gliclazide treatment reduces bone loss is linear compared with a ligature, 5 mg / kg of gliclazide, and 10 mg / kg of gliclazide treatment.

All concentrations of gliclazide increase bone volume / tissue volume (BV / TV) compared with a binder. Treatment with 1 mg / kg of gliclazide reduce myeloperoxidase activity, malondialdehyde, IL-1β and TNF-α levels (P ≤ 0.05), and results in weak staining for COX-2, cathepsin K, MMP-2, RANK, RANKL , -1 SOD, GPx-1, MIF and PI3K. Furthermore, down-regulation of NF-kB p50, PI3K, Akt, and F4 / 80 were observed, and OPG strong staining after treatment 1 mg / kg of gliclazide treatment.This decreased migration of neutrophils and macrophages, decreased inflammatory response, and decreased bone loss in rats with ligature-induced periodontitis.

Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model.
Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model.

Preventing gliclazide 5-FU-Induced Oral Mucositis by Reducing Oxidative Stress, Inflammation, and P-Selectin Adhesion Molecules.

Oral mucositis (OM) is one of the main side effects of the treatment of head and neck cancers, particularly radiotherapy and / or chemotherapy. OM is characterized by ulcers, erythema, dysphagia, xerostomia, and increased susceptibility to opportunistic infections. In the perspective of finding a pharmacological therapy to prevent inflammation and ulceration of the OM, the investigation of the pleiotropic effects of commercial drugs are needed, including gliclazide, antidiabetic drugs.

This study aimed to evaluate the effect of gliclazide in experimental models of OM induced by 5-fluorouracil. male hamster pre-treated with oral gliclazide (1, 5, or 10 mg / kg) for 10 days. Cheek pouch samples were subjected to histopathological and immunohistochemical analysis (COX2, iNOS, MMP-2, NF P65, GPx) and imunofluorescence (P-selectin). IL-1β and TNF-α levels, Myeloperoxidase activity (MPO) and the level of malondialdehyde (MDA) was investigated by ultraviolet-visible spectroscopy analysis.

NFKB1 antibody

10R-11155 100 ug
EUR 418.8
Description: Mouse Monoclonal NFKB1 antibody

NFKB1 antibody

20-PR03 100 ul
EUR 682.8
Description: Rabbit polyclonal NFKB1 antibody

NFKB1 antibody

39087-100ul 100ul
EUR 302.4

NFKB1 Antibody

BF0466 200ul
EUR 540

NFKB1 antibody

70R-10525 50 ug
EUR 560.4
Description: Affinity purified rabbit polyclonal NFKB1 antibody

NFKB1 antibody

70R-18860 50 ul
EUR 522
Description: Rabbit polyclonal NFKB1 antibody

NFKB1 antibody

70R-15433 100 ug
EUR 392.4
Description: Rabbit polyclonal NFKB1 antibody

NFKB1 Antibody

35588-100ul 100ul
EUR 302.4

NFKB1 Antibody

1-CSB-PA003430
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IP, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IP:2-5ug/mglysate.ELISA:1/10000

NFKB1 Antibody

1-CSB-PA003431
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000

NFKB1 Antibody

1-CSB-PA003434
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000

NFKB1 Antibody

1-CSB-PA004763
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

NFKB1 Antibody

1-CSB-PA10354A0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF, ChIP; Recommended dilution: WB:1:500-1:5000, IHC:1:100-1:500, IF:1:50-1:500

NFKB1 Antibody

1-CSB-PA259078
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:500-1:5000, IHC:1:5-1:20

NFKB1 Antibody

1-CSB-PA020085
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

NFKB1 Antibody

1-CSB-PA020086
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/5000

NFKB1 Antibody

1-CSB-PA020090
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

NFKB1 Antibody

1-CSB-PA020096
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

NFKB1 Antibody

1-CSB-PA015759GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

NFKB1 Antibody

1-CSB-PA441503
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:1000-1:2000, WB:1:200-1:1000

NFKB1 Antibody

1-CSB-PA546304
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:500-1:5000, IHC:1:25-1:100

NFKB1 Antibody

F52441-0.4ML 0.4 ml
EUR 330.65
Description: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NFkB is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NFkB complexes are held in the cytoplasm in an inactive state complexed with members of the NFkB inhibitor (I-kappa-B) family. In a conventional activation pathway, IkB is phosphorylated by IkB kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NFkB complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NFkB p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NFkB proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.

NFKB1 Antibody

F54028-0.1ML 0.1 ml
EUR 322.15
Description: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. [UniProt]

NFKB1 Antibody

F47079-0.4ML 0.4 ml
EUR 322.15
Description: This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene.

NFKB1 Antibody

R20321-0.1ML 100ul
EUR 347.65
Description: This antibody reacts to human nuclear factor-kappa-B p105 subunit and p50 subunit.

NFKB1 Antibody

R31224 100 ug
EUR 356.15
Description: Nuclear factor NF-kappa-B p105/p50, also called EBP-1 is a protein that in humans is encoded by the NFKB1 gene. By fluorescence in situ hybridization, the gene was assigned to human chromosome 4q24. NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing.

NFKB1 antibody (HRP)

60R-2109 100 ug
EUR 392.4
Description: Rabbit polyclonal NFKB1 antibody (HRP)

NFKB1 antibody (FITC)

60R-2110 100 ug
EUR 392.4
Description: Rabbit polyclonal NFKB1 antibody (FITC)

NFKB1 Antibody (p105)

F52441-0.08ML 0.08 ml
EUR 140.25
Description: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NFkB is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NFkB complexes are held in the cytoplasm in an inactive state complexed with members of the NFkB inhibitor (I-kappa-B) family. In a conventional activation pathway, IkB is phosphorylated by IkB kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NFkB complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NFkB p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NFkB proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.

NFKB1 Antibody (p105)

F47079-0.08ML 0.08 ml
EUR 140.25
Description: This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene.

Anti-NFkB p105/p50/NFKB1 Antibody

PB9149 100ug/vial
EUR 400.8

Anti-NFkB p105/p50/NFKB1 Antibody

PA2111 100ug/vial
EUR 352.8

Anti-NFkB p105/p50/NFKB1 Antibody

PA2111-1 100ug/vial
EUR 352.8

NFKB1 antibody (biotin)

60R-2111 100 ug
EUR 392.4
Description: Rabbit polyclonal NFKB1 antibody (biotin)

NFKB1 (pS337) Antibody

20-abx000177
  • EUR 594.00
  • EUR 844.80
  • EUR 427.20
  • 100 ul
  • 200 ul
  • 50 ul

NFKB1 (pS927) Antibody

20-abx000315
  • EUR 594.00
  • EUR 844.80
  • EUR 427.20
  • 100 ul
  • 200 ul
  • 50 ul

NFKB1 (pS893) Antibody

20-abx000462
  • EUR 594.00
  • EUR 844.80
  • EUR 427.20
  • 100 ul
  • 200 ul
  • 50 ul

NFKB1 (pS907) Antibody

20-abx000463
  • EUR 594.00
  • EUR 844.80
  • EUR 427.20
  • 100 ul
  • 200 ul
  • 50 ul

NFKB1 (pS932) Antibody

20-abx000464
  • EUR 594.00
  • EUR 844.80
  • EUR 427.20
  • 100 ul
  • 200 ul
  • 50 ul

anti- NFKB1,p105,p50-Specific antibody

FNab05704 100µg
EUR 702
Description: Antibody raised against NFKB1,p105,p50-Specific

NFKB1 Conjugated Antibody

C39087 100ul
EUR 476.4

NFKB1 Conjugated Antibody

C35588 100ul
EUR 476.4

NFKB1 Polyclonal Antibody

A71337
  • EUR 302.50
  • EUR 423.50
  • 50 ul
  • 100 ul

NFKB1 Polyclonal Antibody

A71338
  • EUR 302.50
  • EUR 423.50
  • 50 ul
  • 100 ul

NFKB1 Polyclonal Antibody

A71339
  • EUR 377.30
  • EUR 577.50
  • 50 ul
  • 100 ul

NFKB1 Polyclonal Antibody

A68309
  • EUR 684.66
  • Ask for price
  • Ask for price
  • EUR 423.50
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

NFKB1 Antibody, HRP conjugated

1-CSB-PA10354B0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

Polyclonal NFKB1 Antibody (S932)

APR04474G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NFKB1 (S932). This antibody is tested and proven to work in the following applications:

NFKB1 Antibody, FITC conjugated

1-CSB-PA10354C0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

NFKB1 (Ab-337) Antibody

CSB-PA186775- each
EUR 402
Description: A polyclonal antibody against NFKB1 (Ab-337). Recognizes NFKB1 (Ab-337) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-337) Antibody

CSB-PA186775-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against NFKB1 (Ab-337). Recognizes NFKB1 (Ab-337) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-932) Antibody

CSB-PA190132- each
EUR 402
Description: A polyclonal antibody against NFKB1 (Ab-932). Recognizes NFKB1 (Ab-932) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-932) Antibody

CSB-PA190132-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against NFKB1 (Ab-932). Recognizes NFKB1 (Ab-932) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-893) Antibody

CSB-PA108426- each
EUR 402
Description: A polyclonal antibody against NFKB1 (Ab-893). Recognizes NFKB1 (Ab-893) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-893) Antibody

CSB-PA108426-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against NFKB1 (Ab-893). Recognizes NFKB1 (Ab-893) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-907) Antibody

CSB-PA696291- each
EUR 402
Description: A polyclonal antibody against NFKB1 (Ab-907). Recognizes NFKB1 (Ab-907) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

NFKB1 (Ab-907) Antibody

CSB-PA696291-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against NFKB1 (Ab-907). Recognizes NFKB1 (Ab-907) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200

Antibody for Human NFKB1

SPC-1303D 0.1ml
EUR 376.8
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is unconjugated.

Antibody for Human NFKB1

SPC-1303D-A390 0.1ml
EUR 433.2
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 390.

Antibody for Human NFKB1

SPC-1303D-A488 0.1ml
EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 488.

Antibody for Human NFKB1

SPC-1303D-A565 0.1ml
EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 565.

Antibody for Human NFKB1

SPC-1303D-A594 0.1ml
EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 594.

Antibody for Human NFKB1

SPC-1303D-A633 0.1ml
EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 633.

Antibody for Human NFKB1

SPC-1303D-A655 0.1ml
EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 655.

Antibody for Human NFKB1

SPC-1303D-A680 0.1ml
EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 680.

Antibody for Human NFKB1

SPC-1303D-A700 0.1ml
EUR 432
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to ATTO 700.

Antibody for Human NFKB1

SPC-1303D-ALP 0.1ml
EUR 426
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Alkaline Phosphatase.

Antibody for Human NFKB1

SPC-1303D-APC 0.1ml
EUR 430.8
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to APC .

Antibody for Human NFKB1

SPC-1303D-APCCY7 0.1ml
EUR 518.4
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to APC/Cy7.

Antibody for Human NFKB1

SPC-1303D-BI 0.1ml
EUR 428.4
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Biotin.

Antibody for Human NFKB1

SPC-1303D-DY350 0.1ml
EUR 523.2
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Dylight 350.

Antibody for Human NFKB1

SPC-1303D-DY405 0.1ml
EUR 494.4
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Dylight 405.

Antibody for Human NFKB1

SPC-1303D-DY488 0.1ml
EUR 471.6
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Dylight 488.

Antibody for Human NFKB1

SPC-1303D-DY594 0.1ml
EUR 476.4
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Dylight 594.

Antibody for Human NFKB1

SPC-1303D-DY633 0.1ml
EUR 464.4
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Dylight 633.

Antibody for Human NFKB1

SPC-1303D-FITC 0.1ml
EUR 423.6
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to FITC.

Antibody for Human NFKB1

SPC-1303D-HRP 0.1ml
EUR 418.8
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to HRP.

Antibody for Human NFKB1

SPC-1303D-P594 0.1ml
EUR 440.4
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to PE/ATTO 594.

Antibody for Human NFKB1

SPC-1303D-PCP 0.1ml
EUR 430.8
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to PerCP.

Antibody for Human NFKB1

SPC-1303D-RPE 0.1ml
EUR 429.6
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to RPE .

Antibody for Human NFKB1

SPC-1303D-STR 0.1ml
EUR 430.8
Description: A polyclonal antibody for NFKB1 from Human | Mouse. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human NF-kappaB p105/p50. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This NFKB1 antibody is conjugated to Streptavidin.

Polyclonal NFKB1 Antibody (Ser893)

APR02410G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NFKB1 (Ser893). This antibody is tested and proven to work in the following applications:

NFKB1 Antibody, Biotin conjugated

1-CSB-PA10354D0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

NFKB1 Antibody NF-kB p105/p50

R31223 100 ug
EUR 356.15
Description: NF-kappa-B p105/p50, also called EBP-1 is a protein that in humans is encoded by the NFKB1 gene. By fluorescence in situ hybridization, the gene was assigned to human chromosome 4q24. NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing.

Monoclonal NFKB1 Antibody, Clone: 5D10

AMM02843G 0.1ml
EUR 633.6
Description: A Monoclonal antibody against Human NFKB1. The antibodies are raised in Mouse and are from clone 5D10. This antibody is applicable in WB and IHC, FC, E

Polyclonal NFKB1 Antibody (N-Terminus)

APR02299G 0.05ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NFKB1 (N-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal NFKB1 Antibody (C-Terminus)

APR02425G 0.05ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NFKB1 (C-Terminus). This antibody is tested and proven to work in the following applications:

Rabbit Anti-Human NFKB1 (aa 930-934) Polyclonal Antibody

CPB-1129RH 100 ul
EUR 552

Rabbit Anti-Human NFKB1 (aa 160-170) Polyclonal Antibody

CPB-1169RH 100 ul
EUR 552

Monoclonal NFKB1 Antibody, Clone: 5D10D11

AMM06674G 0.1ml
EUR 633.6
Description: A Monoclonal antibody against Human NFKB1. The antibodies are raised in Mouse and are from clone 5D10D11. This antibody is applicable in WB and IHC, FC, ICC, E

Monoclonal NFKB1 Antibody, Clone: 1298CT792.105.117.133

AMM02481G 0.1ml
EUR 580.8
Description: A Monoclonal antibody against Human NFKB1. The antibodies are raised in Mouse and are from clone 1298CT792.105.117.133. This antibody is applicable in WB, FC, IHC-P, E

NFKB1,p105,p50-Specific Antibody

abx235704-100ug 100 ug
EUR 661.2

Rabbit Anti-Human NFKB1 Polyclonal Antibody, aa.335-339

CPB-932RH 100 ul
EUR 552

Rabbit Anti-Human NFKB1 Polyclonal Antibody, aa.891-895

CPB-933RH 100 ul
EUR 552

Rabbit Anti-Human NFKB1 Polyclonal Antibody, aa.905-909

CPB-934RH 100 ul
EUR 552

NFKB1 Polyclonal Antibody, HRP Conjugated

A54118
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

NFKB1 Polyclonal Antibody, FITC Conjugated

A54119
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

NFKB1 Polyclonal Antibody, Biotin Conjugated

A54120
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

Rabbit Anti-Human NFKB1 Polyclonal Antibody, Phospho-Ser932

CPB-782RH 100 ul
EUR 670.8

Rabbit Anti-Human NFKB1 Polyclonal Antibody, Phospho-Ser927

CPB-827RH 100 ul
EUR 670.8

Monoclonal NFKB1 Antibody (clone 4D1), Clone: 4D1

AMM01706G 0.05mg
EUR 580.8
Description: A Monoclonal antibody against Human NFKB1 (clone 4D1). The antibodies are raised in Mouse and are from clone 4D1. This antibody is applicable in WB and IHC-P, IF

Monoclonal NFKB1 Antibody (monoclonal) (M01), Clone: 2E7

AMM03852G 0.1mg
EUR 580.8
Description: A Monoclonal antibody against Human NFKB1 (monoclonal) (M01). The antibodies are raised in mouse and are from clone 2E7. This antibody is applicable in WB and IF

Monoclonal NFKB1 Antibody (monoclonal) (M03), Clone: 3F6

AMM03853G 0.1mg
EUR 580.8
Description: A Monoclonal antibody against Human NFKB1 (monoclonal) (M03). The antibodies are raised in Mouse and are from clone 3F6. This antibody is applicable in WB, IHC and IF, E

Nuclear Factor NF-Kappa-B P105 Subunit (NFKB1) Antibody

abx235702-100ug 100 ug
EUR 577.2

Nuclear Factor NF-Kappa-B P105 Subunit (NFKB1) Antibody

abx235703-100ug 100 ug
EUR 661.2

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

20-abx242426
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

20-abx242430
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

20-abx214289
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

20-abx324482
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

20-abx324959
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Nuclear Factor NF-Kappa-B P105 Subunit (NFKB1) Antibody

abx412253-50ug 50 ug
EUR 610.8

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

abx330425-100ul 100 ul
EUR 510

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

abx330426-100ul 100 ul
EUR 510

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

abx332073-100ul 100 ul
EUR 510

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

abx332102-100ul 100 ul
EUR 510

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

20-abx326175
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

20-abx326176
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

20-abx326651
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Nuclear Factor NF-Kappa-B P105 Subunit (NFKB1) Antibody

20-abx114173
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Nuclear Factor NF-Kappa-B P105 Subunit (NFKB1) Antibody

abx015941-100ul 100 ul
EUR 493.2

Nuclear Factor NF-Kappa-B P105 Subunit (NFKB1) Antibody

abx038408-100ug 100 ug
EUR 469.2

Nuclear Factor NF-Kappa-B P105 Subunit (NFKB1) Antibody

abx125423-50ul 50 ul
EUR 493.2

Nuclear Factor NF-Kappa-B P105 Subunit (NFKB1) Antibody

20-abx126239
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

20-abx323521
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

20-abx328521
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Nuclear factor NF-kappa-B p105 subunit (NFKB1) Antibody

20-abx328522
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Nuclear Factor NF-Kappa-B P105 Subunit (NFKB1) Antibody

20-abx005113
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Nuclear Factor NF-Kappa-B P105 Subunit (NFKB1) Antibody

abx011949-100ul 100 ul
EUR 493.2

Human NFKB1(NFKB1) ELISA Kit

QY-E05433 96T
EUR 433.2

Nuclear Factor NF-Kappa-B P50 Subunit (NFkB p50/NFKB1) Antibody

abx412254-50ug 50 ug
EUR 610.8

Nuclear Factor NF-Kappa-B P105 Subunit (NFKB1) Antibody Pair

abx117506-1pair5x96wellplates 1 pair (5x96 well plates)
EUR 1212

NFKB1 siRNA

20-abx925825
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

NFKB1 siRNA

20-abx925826
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

Kappa (NFKB1)

MO47031 100 ul
EUR 418.8

Rabbit Anti Human NFKB1 Monoclonal Clone ID-14

IRBAHUNFKB1ID14C100UL each
EUR 496
Description: Rabbit Anti Human NFKB1 Monoclonal Clone ID-14

anti- NFKB2 antibody

FNab05705 100µg
EUR 606.3
Description: Antibody raised against NFKB2

anti- NFKB2 antibody

FNab05706 100µg
EUR 658.5
Description: Antibody raised against NFKB2

NFKB1 Rabbit pAb

A11160-100ul 100 ul
EUR 369.6

NFKB1 Rabbit pAb

A11160-200ul 200 ul
EUR 550.8

NFKB1 Rabbit pAb

A11160-20ul 20 ul
EUR 219.6

NFKB1 Rabbit pAb

A11160-50ul 50 ul
EUR 267.6

NFKB1 Rabbit pAb

A14754-100ul 100 ul
EUR 369.6

NFKB1 Rabbit pAb

A14754-200ul 200 ul
EUR 550.8

NFKB1 Rabbit pAb

A14754-20ul 20 ul
EUR 219.6

NFKB1 Rabbit pAb

A14754-50ul 50 ul
EUR 267.6

Nuclear factor NF-kappa-B p105 subunit Phospho-Ser893 (NFKB1 pS893) Antibody

20-abx324483
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

NLS NF P50 protein levels were analyzed by western blotting. The group treated with gliclazide at a dose of 10 mg / kg showed the presence of erythema, there was no evidence of erosion, and the absence of mucosal ulceration with a score of 1 (1-2) (p <0.01).

Recent Posts

Tags

December 2023
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031

Categories

Pages